Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David P Lane

Showing results (161-170 of 235) with videos related to

Pageof 24
Sort By:
Cell Cycle (Georgetown, Tex.)|December 21, 2012
Wild-type and mutant p53 mediate cisplatin resistance through interaction and inhibition of active caspase-9Jacqueline L Y Chee, Suzan Saidin, David P Lane, et al.
Molecular Cancer Therapeutics|January 20, 2005
Metabolism and pharmacokinetics of the cyclin-dependent kinase inhibitor R-roscovitine in the mouseBernard P Nutley, Florence I Raynaud, Stuart C Wilson, et al.
The Journal of Physical Chemistry Letters|July 6, 2018
Mass Spectrometry Reveals the Direct Action of a Chemical ChaperoneJoseph Gault, Danai Lianoudaki, Margit Kaldmäe, et al.
Cancer Research|March 17, 2006
Tumor susceptibility and apoptosis defect in a mouse strain expressing a human p53 transgeneCrissy Dudgeon, Calvina Kek, Oleg N Demidov, et al.
Cell Reports|January 4, 2018
Monoclonal Antibodies against Specific p53 Hotspot Mutants as Potential Tools for Precision MedicineLe-Ann Hwang, Beng Hooi Phang, Oi Wah Liew, et al.
Autophagy|February 4, 2021
CD36 and LC3B initiated autophagy in B cells regulates the humoral immune responseChenfei He, Shan Wang, Chikai Zhou, et al.
Molecular Oncology|October 17, 2025
CDK11 inhibition induces cytoplasmic p21<sup>WAF1</sup> splice variant by p53 stabilisation and SF3B1 inactivationRadovan Krejcir, Lukasz Arcimowicz, Lucia Martinkova, et al.
Molecular Pharmaceutics|April 30, 2025
Engineered Peptide Coacervates Enable Efficient Intracellular Delivery of the MYC Inhibitor omoMYCCarmine P Cerrato, Martin Krkoška, Yue Sun, et al.
BMC Cancer|October 3, 2008
MDM2 SNP309 is associated with high grade node positive breast tumours and is in linkage disequilibrium with a novel MDM2 intron 1 polymorphismFiona E M Paulin, Mary O'Neill, Gillian McGregor, et al.
Cell Research|February 21, 2015
p53 isoform Δ113p53/Δ133p53 promotes DNA double-strand break repair to protect cell from death and senescence in response to DNA damageLu Gong, Hongjian Gong, Xiao Pan, et al.
Pageof 24

Showing results (161-170 of 235) with videos related to

Sort By:
Pageof 24
Cell Cycle (Georgetown, Tex.)|December 21, 2012
Wild-type and mutant p53 mediate cisplatin resistance through interaction and inhibition of active caspase-9Jacqueline L Y Chee, Suzan Saidin, David P Lane, et al.
Molecular Cancer Therapeutics|January 20, 2005
Metabolism and pharmacokinetics of the cyclin-dependent kinase inhibitor R-roscovitine in the mouseBernard P Nutley, Florence I Raynaud, Stuart C Wilson, et al.
The Journal of Physical Chemistry Letters|July 6, 2018
Mass Spectrometry Reveals the Direct Action of a Chemical ChaperoneJoseph Gault, Danai Lianoudaki, Margit Kaldmäe, et al.
Cancer Research|March 17, 2006
Tumor susceptibility and apoptosis defect in a mouse strain expressing a human p53 transgeneCrissy Dudgeon, Calvina Kek, Oleg N Demidov, et al.
Cell Reports|January 4, 2018
Monoclonal Antibodies against Specific p53 Hotspot Mutants as Potential Tools for Precision MedicineLe-Ann Hwang, Beng Hooi Phang, Oi Wah Liew, et al.
Autophagy|February 4, 2021
CD36 and LC3B initiated autophagy in B cells regulates the humoral immune responseChenfei He, Shan Wang, Chikai Zhou, et al.
Molecular Oncology|October 17, 2025
CDK11 inhibition induces cytoplasmic p21<sup>WAF1</sup> splice variant by p53 stabilisation and SF3B1 inactivationRadovan Krejcir, Lukasz Arcimowicz, Lucia Martinkova, et al.
Molecular Pharmaceutics|April 30, 2025
Engineered Peptide Coacervates Enable Efficient Intracellular Delivery of the MYC Inhibitor omoMYCCarmine P Cerrato, Martin Krkoška, Yue Sun, et al.
BMC Cancer|October 3, 2008
MDM2 SNP309 is associated with high grade node positive breast tumours and is in linkage disequilibrium with a novel MDM2 intron 1 polymorphismFiona E M Paulin, Mary O'Neill, Gillian McGregor, et al.
Cell Research|February 21, 2015
p53 isoform Δ113p53/Δ133p53 promotes DNA double-strand break repair to protect cell from death and senescence in response to DNA damageLu Gong, Hongjian Gong, Xiao Pan, et al.
Pageof 24